External resources Sigma-Aldrich - Peptide stability and potential degradation pathways PubMed Central - Factors affecting physical stability of peptide therapeutics For researchers serious about protecting their peptide investments and optimizing every protocol, SeekPeptides provides comprehensive storage guides, stability databases, and handling protocols for members
The therapeutic effect of L-carnitine in patients with exercise-induced stable angina: a controlled study
Cardiovascular Health Cardiovascular disease is the leading cause of premature death in men in the UK, and men develop it on average ten years earlier than women
Research is needed to help illustrate the size and nature of access gaps so that we can design better coverage policies. Ultimately, there is a need for policymakers to recognize that factors unrelated to whether an individual has a medical necessity for treatment can affect whether or not a person is likely to receive these medications, says study lead author Meghan Podolsky (SPH24), research fellow in the Department of Global Health and an SPH alum who completed the MS program in epidemiology last year
There are multiple amylins in phase II trials, including Amycretin (another dual amylin/GLP-1 agonist, Novo Nordisk) and Eloralintide (a single-target amylin analogue, Eli Lilly)
AZs small-molecule GLP-1R agonist (licensed from Chinas Eccogene) hit Phase 2 endpoints and is moving into Phase 3
